Literature DB >> 17476086

Use of a pediatric end-stage liver disease score for deceased donor allocation: the United States experience.

Sue V McDiarmid1, Robert M Merion, Dawn M Dykstra, Ann M Harper.   

Abstract

The Pediatric end-stage liver disease (PELD) score was developed as a measure of the severity of chronic liver disease that would predict mortality or children awaiting liver transplant. From multivariate analyses a model was derived that included five objective factors which together comprise the PELD score. The factors are growth failure, age less than 1 year, international normalized ratio (INR), serum albumin and total bilirubin.

Entities:  

Mesh：

Year:  2007        PMID： 17476086     DOI： 10.1007/s12098-007-0066-2

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN： 0019-5456            Impact factor:   5.319


  11 in total

1.  MELD and PELD: application of survival models to liver allocation.

Authors:  R H Wiesner; S V McDiarmid; P S Kamath; E B Edwards; M Malinchoc; W K Kremers; R A Krom; W R Kim
Journal:  Liver Transpl       Date:  2001-07       Impact factor: 5.799

2.  Organ Procurement and Transplantation Network--HRSA. Final rule with comment period.

Authors: 
Journal:  Fed Regist       Date:  1998-04-02

3.  New liver allocation policies and their potential effect on pediatric patients awaiting liver transplantation.

Authors:  Sue V McDiarmid
Journal:  Pediatr Transplant       Date:  2002-06

4.  Factors affecting growth after pediatric liver transplantation.

Authors:  S V McDiarmid; J A Gornbein; P J DeSilva; J A Goss; J H Vargas; M G Martín; M E Ament; R W Busuttil
Journal:  Transplantation       Date:  1999-02-15       Impact factor: 4.939

5.  Studies of Pediatric Liver Transplantation (SPLIT): year 2000 outcomes.

Authors: 
Journal:  Transplantation       Date:  2001-08-15       Impact factor: 4.939

Review 6.  A model to predict survival in patients with end-stage liver disease.

Authors:  P S Kamath; R H Wiesner; M Malinchoc; W Kremers; T M Therneau; C L Kosberg; G D'Amico; E R Dickson; W R Kim
Journal:  Hepatology       Date:  2001-02       Impact factor: 17.425

7.  The survival benefit of liver transplantation.

Authors:  Robert M Merion; Douglas E Schaubel; Dawn M Dykstra; Richard B Freeman; Friedrich K Port; Robert A Wolfe
Journal:  Am J Transplant       Date:  2005-02       Impact factor: 8.086

8.  Summary report of a national conference: Evolving concepts in liver allocation in the MELD and PELD era. December 8, 2003, Washington, DC, USA.

Authors:  Kim M Olthoff; Robert S Brown; Francis L Delmonico; Richard B Freeman; Sue V McDiarmid; Robert M Merion; J Michael Millis; John P Roberts; Abraham Shaked; Russell H Wiesner; Michael R Lucey
Journal:  Liver Transpl       Date:  2004-10       Impact factor: 5.799

9.  The new liver allocation system: moving toward evidence-based transplantation policy.

Authors:  Richard B Freeman; Russell H Wiesner; Ann Harper; Sue V McDiarmid; Jack Lake; Erick Edwards; Robert Merion; Robert Wolfe; Jeremiah Turcotte; Lewis Teperman
Journal:  Liver Transpl       Date:  2002-09       Impact factor: 5.799

10.  Development of a pediatric end-stage liver disease score to predict poor outcome in children awaiting liver transplantation.

Authors:  Sue V McDiarmid; Ravinder Anand; Anne S Lindblad
Journal:  Transplantation       Date:  2002-07-27       Impact factor: 4.939
View more
  1 in total

1.  Predictors of survival following liver transplantation in infants: a single-center analysis of more than 200 cases.

Authors:  Robert S Venick; Douglas G Farmer; Sue V McDiarmid; John P Duffy; Sherilyn A Gordon; Hasan Yersiz; Johnny C Hong; Jorge H Vargas; Marvin E Ament; Ronald W Busuttil
Journal:  Transplantation       Date:  2010-03-15       Impact factor: 4.939
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.